References
- Boyle P, Severi G, Giles GG (2003). The epidemiology of prostate cancer. Urol Clin North Am, 30, 209-17. https://doi.org/10.1016/S0094-0143(02)00181-7
- Bioteach. Assessed 14 December 2005 www.bioteach.ubc.ca/Biomedicine/ProstateCancer/
- CA: A Cancer Journal for Clinicians 61:Issue 2, MARCH/APRIL 2011. Article first published online: 4 FEB 2011. Available online at http://cajournal.org and http://cacancerjournal.org.
- Chou Roger, Croswel M Jennifer, Dana Tracy, et al (2011). screening for prostate cancer: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med, 155,762-71. https://doi.org/10.7326/0003-4819-155-11-201112060-00375
- Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet].IARC, Lyon.
- Higginbotham JC, Moulder J, Currier M (2001). Rural v. urban aspects of cancer: first-year data from the Mississippi Central Cancer Registry. Fam Community Health, 24, 1-9.
- Larranaga N, Galceran J, Ardanaz E, et al (2010). Prostate cancer incidence trends in Spain before and during the prostatespecific antigen era: impact on mortality. Ann Oncol, 21, 83-9
- McLafferty S, Wang F (2009). Rural reversal? Rural-urban disparities in late-stage cancer risk in Illinois. Cancer, 115, 2755-64. https://doi.org/10.1002/cncr.24306
- Merrill RM, Feuer EJ, Warren JL et al (1999). Role of transurethral resection of the prostate in population-based prostate cancer incidence rates. Am J Epidemiol, 150, 848- 60. https://doi.org/10.1093/oxfordjournals.aje.a010090
- Muir CS, Nectoux J, Staszewski J (1991). The epidemiology of prostatic cancer. Geographical distribution and time-trends. Acta Oncol, 30, 133-40. https://doi.org/10.3109/02841869109092336
- Potosky AL, Kessler L, Gridley G, et al (1990). Rise in prostatic cancer incidence associated with increased use of transurethral resection. J Natl Cancer Inst, 82, 1624-8. https://doi.org/10.1093/jnci/82.20.1624
- Potosky AL, Miller BA, Albertsen PC et al (1995). The role of increasing detection in the rising incidence of prostate cancer. JAMA, 273, 548-52. https://doi.org/10.1001/jama.1995.03520310046028
- Yavuz SS, Dilek S, Aye TS, et al (2008). Dietary agents in prevention of prostate cancer. Asian Pac J Cancer Prev, 9, 183-6.
Cited by
- Bisphosphonates for Osteoporosis in Nonmetastatic Prostate Cancer Patients Receiving Androgen-deprivation Therapy: A Systematic Review and Meta-analysis vol.14, pp.5, 2013, https://doi.org/10.7314/APJCP.2013.14.5.3337
- Laser Induced Fluorescence Studies of Blood Plasma and Tumor Tissue of Men with Prostate Tumors vol.05, pp.11, 2014, https://doi.org/10.4236/jct.2014.511107
- Histopathologic Characterization of Prostate Diseases in Madinah, Saudi Arabia vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4175
- Frequency of Unnecessarily Biopsies among Patients with Suspicion of Prostate Cancer in Syrian Men vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5967
- Oral exposure to hexavalent chromium through drinking water and urologic morbidity in an industrial area of Greece vol.23, pp.5, 2015, https://doi.org/10.1007/s10389-015-0681-8
- Diagnostic and treatment factors associated with poor survival from prostate cancer are differentially distributed between regional and metropolitan Victoria, Australia vol.16, pp.1, 2016, https://doi.org/10.1186/s12894-016-0172-4
- Prostate Cancer in Iran: Trends in Incidence and Morphological and Epidemiological Characteristics vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.839